The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vincristine     Quarter: 2016Q3

Total Records: 1,179     Number of Pages: 59

DRUGNAME PT EventCount
Vincristine Condition aggravated 6
Vincristine Drug interaction 6
VINCRISTINE Enterovesical fistula 6
VINCRISTINE Foetal exposure during pregnancy 6
VINCRISTINE General physical health deterioration 6
Vincristine Haemorrhage 6
VINCRISTINE Intracranial venous sinus thrombosis 6
Vincristine Lung disorder 6
vincristine Lymphocytosis 6
VINCRISTINE Meningitis tuberculous 6
VINCRISTINE Pneumonitis 6
vincristine Protein total decreased 6
VINCRISTINE Urinary tract infection 6
vincristine Vitamin B12 increased 6
vincristine Hospira Acute prerenal failure 6
VINCRISTINE SULFATE. Acute myeloid leukaemia 6
VINCRISTINE SULFATE. Atelectasis 6
VINCRISTINE SULFATE. Blood bilirubin increased 6
VINCRISTINE SULFATE. Disease recurrence 6
VINCRISTINE SULFATE. Hyperbilirubinaemia 6

Total Records: 1,179     Number of Pages: 59